GLP-1 Research

GLP-1 medications can drive significant muscle loss alongside fat loss — here is what the latest research reveals…

New research shows GLP-1 receptor agonists reduce kidney-related outcomes — including creatinine doubling — by up to 24%,…

If your oral GLP-1 medication isn't producing results, the problem is rarely the drug itself — here's what…

Up to 45% of semaglutide-driven weight loss can come from muscle — here's the evidence-based strategy to stop…

A 2026 indirect treatment comparison confirms that oral semaglutide 25 mg delivers clinically comparable weight loss to injectable…

New clinical trial data shows semaglutide may actually protect kidney function in men with CKD — but the…

Up to 45% of weight lost on semaglutide can come from skeletal muscle — here's what the latest…

Injecting Ozempic into muscle instead of subcutaneous fat can disrupt the drug's absorption profile, intensify side effects, and…

Emerging research reveals that GLP-1 medications may offer significant neuroprotective benefits — and the underlying brain health pathways…

Semaglutide has strong clinical evidence supporting its safety and efficacy for weight loss, but men should understand its…